The safety of total daily dose greater than 30 mg (or 10 mg injections given more frequently than 2 hours after the initial dose and 4 hours after the second dose) has not been evaluated in clinical trials; maximal dosing may be associated with significant orthostatic hypotension. If ongoing ...